Strategic advice & alerts to leverage data analytics & new technologies

Leverage data and the technologies that generate it, from ML, IA, NLP, blockchain, IoT, and emerging tech; to data science, data visualization, predictive modeling; to data quality, data governance, and data architecture.

Learn More

Recently Published

One of the many consequences of the COVID-19 crisis has been difficulty in continuing to enroll and run clinical trials, which typically involve large numbers of people interacting in multiple geographies. In this Executive Update, we highlight a new, risk-based predictive analytical approach, powered by machine learning.
Intelligent process automation continues to generate a lot of interest. And today, IPA is touted as an important technology offering potential benefits for almost every industry. But just how do end-user organizations feel about the prospects for IPA to live up to its expectations?
Part I of this Executive Update series on intelligent process automation (IPA) in the enterprise looks at the current and future status of IPA in the organization.
How can mHealth support the new challenges and opportunities of telehealth? In this issue of Cutter Business Technology Journal (CBTJ), we present some stimulating articles that illustrate the impact now, and the future direction, of mHealth.
If the familiar VPNs are not up to the task of supporting the sudden new generation of WFH users, what’s the alternative? Fortunately, there’s a class of products designed specifically for today’s needs: cloud-based remote access software.
With a focus on brain health and neuroscience, Sean Lorenz describes how technology is helping us better assess our brain health journeys with remote detection, diagnosis, and treatment tools. Given the issues surrounding the COVID-19 pandemic, he explores the urgent need that requires the healthcare system to actively look toward telehealth and RPM.
This article moves us up the healthcare value chain by highlighting the impact that COVID-19 has had on clinical trials. Cutter Consortium Senior Consultant Ben van der Schaaf and Pan Xi describe the current state of mHealth along with technology innovations that forward-looking R&D leaders in pharmaceuticals are deploying. Knowing that the current shift will not be temporary, the authors urge healthcare organizations “to adapt and be in the right place at the right time … to prepare for this imminent change.”
Heléne Spjuth examines the economics of mHealth and the resulting challenges and opportunities for all stakeholders in the healthcare ecosystem. In defining the healthcare ecosystem and its various reimbursement models, she shows the “unique circumstances that will serve either as barriers to, or enablers of, mHealth’s efficient implementation.”